EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
201
PAGES
353
EDITION
20
PRICE
USD 5600
CODE
MCP-1833
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Botulinum Toxin Market to Reach $8.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Botulinum Toxin estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$8.5 Billion by 2027, growing at aCAGR of 8.2% over the period 2020-2027. Type A, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$8.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Type B segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 14.8% CAGR
The Botulinum Toxin market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$762.1 Million by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 6.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
SELECT PLAYERS
AbbVie; Daewoong Pharmaceutical Co., Ltd.; HUGEL Pharma; Ipsen Group; Medy-Tox Inc.; Merz Pharma GmbH & Co. KGaA; Metabiologics, Inc.; Revance Therapeutics, Inc.; US WorldMeds
SEGMENTS
» Product (Type A, Type B) » Application (Therapeutics, Aesthetics) » End-Use (Specialty & Dermatology Clinics, Hospitals & Clinics, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
COVID-19 Disruptions Impact Botulinum Toxin Business |
Virtual Care to the Fore amid COVID-19 |
Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID‐19 Infection Transmission |
EXHIBIT: % Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020 |
COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions |
Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection |
Botulinum Toxin – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Botulinum Toxin: An Introduction |
Outlook |
Therapeutic BTX Applications Lead |
Cosmetic BTX Gradually Gains Momentum |
Factors Propelling the Cosmetic BT Market: In a Nut Shell |
EXHIBIT: Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019 |
Developed Regions Dominate Botulinum Toxin Market |
Developing Markets to Drive Future Growth |
Competitive Landscape |
Intense Competition Characterizes Botulinum Toxin Market |
EXHIBIT: Market Share of Leading Players in Global Botulinum Toxin Market: 2019 |
Select Approved Botulinum Toxin Products Worldwide |
Companies Entering the Fray |
Pharma Companies Eye Lucrative BT Market |
Biosimilar BTX Variants Challenge Botox’s Leadership |
Lack of Differentiation among Approved BTX Products |
Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy |
Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval |
BOTOX® |
Ipsen Counts on New Indications for Future Growth of Dysport |
Xeomin® |
Merz |
Other Products |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market |
EXHIBIT: Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes |
Botulinum Toxin: The Preferred Solution in Facial Injectables Market |
EXHIBIT: Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender |
Millennials: A Popular Demographic for Botulinum Toxin |
EXHIBIT: Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share |
Therapeutic Areas and Opportunities |
Botox Therapeutic Applications Uses and Indications |
EXHIBIT: Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019) |
Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity |
Rise in the Number of Musculoskeletal Indications: Potential for Growth |
Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation? |
Combination Therapies: A Double Whammy Success |
Botulinum Toxin: Potential Applications in Treatment of Dental Diseases |
Potential Applications in Dentistry |
Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments |
Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin |
Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX |
EXHIBIT: Life Expectancy at Birth in Years of People in Select Countries |
EXHIBIT: Life Expectancy at Birth (in Years) of Men and Women by Region |
Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications |
Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017 |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
Challenges and Issues |
Undesirable Side Effects: A Challenge to Reckon With |
Immunogenicity Undermines Patient Compliance |
Antigenicity: A Problematic Issue in Drug Development |
Potential Adverse Side Effects: A Major Barrier to Success |
Stringent Regulations Delay Market Approvals |
Higher Product Costs to Challenge Market Growth |
Consumer Skepticism: The Biggest Challenge to Beat |
Animal Cruelty:A Part & Parcel of Botox Testing |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
Market Overview |
Opportunities in Store for Cosmetic BTX |
EXHIBIT: Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019 |
EXHIBIT: Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019) |
Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market |
Cosmetic Procedures: Facts and Figures |
Aging Baby Boomers Drive Aesthetic Business |
EXHIBIT: US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups |
EXHIBIT: North American Aging Population by Age Group: 1975-2050 |
Expanding Physician Base Extends Impetus to Growth |
Therapeutic BTX Seeks Growth Opportunities |
Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval |
Neurogenic OAB: A Lucrative Market Opportunity |
Competitive Landscape |
Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market |
EXHIBIT: Market Share of Leading Brands in the US Boulinum Toxin Market: 2019 |
Dysport Poses Strong Competition to Botox in the Therapeutic Space |
USA Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
JAPAN |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Market Overview |
EXHIBIT: Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share |
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
CHINA |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
Market Overview |
Uptrend in Facial Injectables Market Favors Market Expansion |
Regulatory Scenario |
Approved Botulinum Toxin Injections in China |
Competition |
Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019 |
China Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
EUROPE |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Market Overview |
Botox Approvals and Indications in Select European Countries |
EXHIBIT: Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type |
Regulations for Botulinum Toxin Usage in the EU |
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
FRANCE |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
GERMANY |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
Market Overview |
Snapshots |
UK Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
RUSSIA |
Market Overview |
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
AUSTRALIA |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
Market Overview |
TABLE: Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type |
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
INDIA |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
Market Overview |
EXHIBIT: Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type |
India Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
SOUTH KOREA |
Market Overview |
Strong Demand for Cosmetic Procedures – Potential for BTX Market |
EXHIBIT: Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018 |
EXHIBIT: Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients |
Competition |
Market Share of Leading Players in Botulinum Toxin Market In South Korea |
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
LATIN AMERICA |
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com